| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
| There are 3 registered members and 58 guests viewing the site. | Follow us on Twitter | Rss Top Picks Feed | Rss Daily Feed |
|
| Comment | 0.570 | Benj Gallander | Impressive company but not impressive enough to buy. Have a number of problems that they still have to deal with. Has the potential of a good turnaround play. | 2012-04-17 | |
| DON'T BUY | 0.540 | Benj Gallander | Losing money. Have a negative cash flow of about $1 million a month, which could continue possibly the end of 2012. This is a real danger signal. | 2011-10-04 | |
| BUY | 0.810 | Serge Depatie | A vaccine that is used in cattle to reduce E. coli. The question is, does it immunize enough. Very promising. Very stable revenue. Trading at only 2X sales so you get their cancer and cattle products for free. | 2008-05-07 | |
| BUY | 0.920 | Geoff Houlton | A very interesting company. Has an animal health product, human health products focused on bladder cancer and a vaccine for cattle. Likes the company, has existing products (short-term revenue stream) and has future opportunity and a potential blockbuster product. A significant opportunity. | 2008-03-26 | |
| WATCH | 0.780 | Benj Gallander | He has done very poorly in this area. This company is on their watch list, but they aren't buying yet. As it's down from where the caller bought, he would be looking at using it as a tax loss. | 2007-10-18 |